For class II HDACs, downregulation of its expression in glioblastoma compared to low-grade gliomas and normal brain tissue was demonstrated and statistically confirmed in our study, indicating a negative correlation between HDAC expression and malignancy in gliomas. This evidence concerns the gene HDAC9 and glioma.